Phase 1 Start~month

Phase 1 Start: A Phase 1a/1b, First Time in Human Study of CT-202, A Nectin-4 Directed Bispecific Antibody, in Part

Drug
ct-202
Indication
Triple Negative Breast Cancer (TNBC); Colorectal Cancer; Urothelial Cancer

Other upcoming events for CNTX

Phase 1 StartPhase 1 Start: A Phase 1a/1b, First Time in Human Study of CT-202, A Nectin-4 Directed Bispecific Antibody, in Part

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: A Phase 1a/1b, First Time in Human Study of CT-202, A Nectin-4 Directed Bispecific Antibody, in Part — CNTX Phase 1 Start | BioSniper